Ash Stevens competitors

Mr. Loewald joined Cambrex in September 2020 and currently serves as Chief Executive Officer. Mr. Loewald is a 15-year veteran of Thermo Fisher Scientific, where he served in several senior executive roles during his tenure, including Chief Commercial Officer, President of the Analytical Instruments Group, President of the Laboratory Products Group, and President of the Laboratory Equipment and Environmental Instrument Divisions. Earlier in his career he held leadership positions at Tyco International and General Electric. Mr. Loewald currently serves on the Board of Directors of Harvard BioScience, a global developer, manufacturer and marketer of a broad range of solutions to advance life science.

Mr. Patel’s lifelong drive and constant desire to discover what’s next has carried Amneal Pharmaceuticals from humble beginnings to an emerging global presence. Patel is the recipient of several industry honors including the 2011 Ernst & Young National Entrepreneur of the Year Life Sciences Award® and supports various philanthropic and charitable causes both in the US and abroad. Patel and his wife, Priti Patel, established the Niswarth Children Foundation in 2013, with the goal of bringing fresh water, sanitation, sustenance, and education to one million underprivileged children. Patel received his bachelor’s degree in commerce from H.A. College of Commerce, India, and his Bachelor of Science in business administration from New Jersey City University. He also received an honorary degree of doctor of humane letters from New Jersey City University in recognition of his efforts to serve others and help them transform their lives. Patel serves on the boards of the Generic Pharmaceutical Association, the Art of Living Foundation, the New Jersey City University Foundation, and the Family Reach Foundation.

Cameron Reid is a Board Member at CHEMINOR DRUGS LIMITED and Chief Executive Officer at Interpharm Holdings Inc. He has worked as President at DR. REDDY'S LABORATORIES and Board Member at Interpharm Holdings Inc. Cameron works or has worked as Executive Vice President at Roussel NV. He studied at UCalgary and INSEAD.

An entrepreneurial executive specializing in growth strategies. Managing, motivating and coaching people toward a common business goal is a core strength. Experience includes Board of Directors, IPO, M&A, Sales, Business Development, Marketing and Operations. Expertise in start-ups to Fortune 6 environments.Applied growth strategies within the following market segments:In Vitro Diagnostics, Instrument Development, Single-Use bioreactors, Gene Expression Analysis, GMP services, Filtration, Cell Culture, Microscopy, Protein Crystallography, Liquid Chromatography, DNA/RNA chemistry, Peptide chemistry, Biologics, Biosimilars and Drug Development.

Stephan Kutzer is a Chief Executive Officer at aaiPharma Inc and Chief Executive Officer at Cambridge Major Laboratories Inc. He has worked as COO:Pharma & Biotech Mkt Segment at Lonza America Inc., Head:Performance Chemicals at Lonza America Inc., and Site Manager:Bayport at Lonza America Inc.. Stephan studied at Technische Universitaet Muenchen.

Tom Ross is a President at Grand River Aseptic Manufacturing and is based in Grand Rapids, Michigan. He has worked as Managing Director at DWH. Thomas studied at Michigan State University.